Single nucleotide polymorphisms of toll-like receptor 7 and toll-like receptor 9 in hepatitis C virus infection patients from central China

Yonsei Medical Journal

Volumn 55, Issue 2, 2014, Pages 428-434

  Wei, Xin Su ^a   Wei, Chuan Dong ^a   Tong, Yong Qing ^a   Zhu, Cheng Liang ^a   Zhang, Ping An ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Hepatitis C virus; Single nucleotide polymorphism; TLR7; TLR9

Indexed keywords

HEPATITIS C VIRUS; SINGLE NUCLEOTIDE POLYMORPHISM; TLR7; TLR9;

ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; CONFIDENCE INTERVALS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEPATITIS C; HEPATITIS C, CHRONIC; HUMANS; LIVER; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9;

EID: 84894267611     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2014.55.2.428     Document Type: Article

References (36)

1. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011;17:107-15.
2. Klevens RM, Hu DJ, Jiles R, Holmberg SD. Evolving epidemiology of hepatitis C virus in the United States. Clin Infect Dis 2012;55 Suppl 1:S3-9.
3. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-76.
4. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004;5:987-95.
5. Arpaia N, Barton GM. Toll-like receptors: key players in antiviral immunity. Curr Opin Virol 2011;1:447-54.
6. Testro AG, Visvanathan K. Toll-like receptors and their role in gastrointestinal disease. J Gastroenterol Hepatol 2009;24:943-54.
7. Askar E, Ramadori G, Mihm S. Toll-like receptor 7 rs179008/ Gln11Leu gene variants in chronic hepatitis C virus infection. J Med Virol 2010;82:1859-68.
8. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004;303:1526-9.
9. Ito T, Amakawa R, Kaisho T, Hemmi H, Tajima K, Uehira K, et al. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med 2002;195:1507-12.
10. Zhang YL, Guo YJ, Bin Li, Sun SH. Hepatitis C virus singlestranded RNA induces innate immunity via Toll-like receptor 7. J Hepatol 2009;51:29-38.
11. Chang S, Kodys K, Szabo G. Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells. Hepatology 2010;51:35-42.
12. Horsmans Y, Berg T, Desager JP, Mueller T, Schott E, Fletcher SP, et al. Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection. Hepatology 2005;42: 724-31.
13. Szabo G, Dolganiuc A, Mandrekar P. Pattern recognition receptors: a contemporary view on liver diseases. Hepatology 2006;44: 287-98.
14. Hu K, Wang GW, Wang ZH. [TLR9 mRNA expression and tumor necrosis factor-alpha/interleukin-6 secretion in murine microglia by hepatitis C virus stimulation]. Zhonghua Yi Xue Za Zhi 2011; 91:1070-4.
15. Broering R, Wu J, Meng Z, Hilgard P, Lu M, Trippler M, et al. Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication. J Hepatol 2008;48:914-22.
16. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783-801.
17. Wang CH, Eng HL, Lin KH, Chang CH, Hsieh CA, Lin YL, et al. TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection. PLoS One 2011;6:e26235.
18. Sawhney R, Visvanathan K. Polymorphisms of toll-like receptors and their pathways in viral hepatitis. Antivir Ther 2011;16:443-58.
19. Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 2008;8:737-44.
20. Song DH, Lee JO. Sensing of microbial molecular patterns by Toll-like receptors. Immunol Rev 2012;250:216-29.
21. Kang JY, Lee JO. Structural biology of the Toll-like receptor family. Annu Rev Biochem 2011;80:917-41.
22. Sato A, Iwasaki A. Induction of antiviral immunity requires Toll-like receptor signaling in both stromal and dendritic cell compartments. Proc Natl Acad Sci U S A 2004;101:16274-9.
23. Wieland SF, Chisari FV. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 2005;79:9369-80.
24. Du X, Poltorak A, Wei Y, Beutler B. Three novel mammalian tolllike receptors: gene structure, expression, and evolution. Eur Cytokine Netw 2000;11:362-71.
25. Cheng PL, Eng HL, Chou MH, You HL, Lin TM. Genetic polymorphisms of viral infection-associated Toll-like receptors in Chinese population. Transl Res 2007;150:311-8.
26. Colonna M, Krug A, Cella M. Interferon-producing cells: on the front line in immune responses against pathogens. Curr Opin Immunol 2002;14:373-9.
27. García-Sastre A, Biron CA. Type 1 interferons and the virus-host relationship: a lesson in détente. Science 2006;312:879-82.
28. Gale M Jr, Foy EM. Evasion of intracellular host defence by hepatitis C virus. Nature 2005;436:939-45.
29. Takahashi K, Asabe S, Wieland S, Garaigorta U, Gastaminza P, Isogawa M, et al. Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc Natl Acad Sci U S A 2010;107:7431-6.
30. Schott E, Witt H, Neumann K, Bergk A, Halangk J, Weich V, et al. Association of TLR7 single nucleotide polymorphisms with chronic HCV-infection and response to interferon-a-based therapy. J Viral Hepat 2008;15:71-8.
31. Schott E, Witt H, Neumann K, Taube S, Oh DY, Schreier E, et al. A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection. J Hepatol 2007;47:203-11.
32. Lockshin MD. Sex differences in autoimmune disease. Lupus 2006;15:753-6.
33. Exploring the biological contributions to human health: does sex matter? J Womens Health Gend Based Med 2001;10:433-9.
34. Jaen O, Petit-Teixeira E, Kirsten H, Ahnert P, Semerano L, Pierlot C, et al. No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis. Arthritis Res Ther 2009;11:R5.
35. Jia N, Xie Q, Lin L, Gui H, Wang H, Jiang S, et al. Common variants of the TLR9 gene influence the clinical course of HBV infection. Mol Med Rep 2009;2:277-81.
36. Chen X, Wang S, Liu L, Chen Z, Qiang F, Kan Y, et al. A genetic variant in the promoter region of Toll-like receptor 9 and cervical cancer susceptibility. DNA Cell Biol 2012;31:766-71.